Your browser doesn't support javascript.
loading
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
Bhargavan, Biju; Woollard, Shawna M; McMillan, Jo Ellyn; Kanmogne, Georgette D.
Afiliação
  • Bhargavan B; Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
  • Woollard SM; Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
  • McMillan JE; Huvepharma, 421 W Industrial Lake Drive, Lincoln, NE, 68528, USA.
  • Kanmogne GD; Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
Mol Neurodegener ; 16(1): 78, 2021 11 22.
Article em En | MEDLINE | ID: mdl-34809709
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Doença de Alzheimer Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Doença de Alzheimer Idioma: En Ano de publicação: 2021 Tipo de documento: Article